Ms. Nicole R. Poole, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 11542 223rd St, Cambria Heights, NY 11411 Phone: 718-712-3818 |
Anne Caroline Theogene, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 11406 227th St, Cambria Heights, NY 11411 Phone: 516-477-6573 Fax: 718-228-9381 |
Mr. Howard Dalston Harrison Jr., MD Physical Therapist - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 11845 Nashville Blvd, Cambria Heights, NY 11411 Phone: 347-357-8048 |
Mr. Steven Skinner, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 11619 228th St, Cambria Heights, NY 11411 Phone: 917-862-4008 |
Dr. Lydia Chike, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 22763 114th Rd, Cambria Heights, NY 11411 Phone: 347-387-4328 |
Sajo Mathew John, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 22004 Linden Blvd, Cambria Heights, NY 11411 Phone: 718-712-3358 |
James Antoine, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 11901 225th St, Cambria Heights, NY 11411 Phone: 347-551-9580 Fax: 718-240-8324 |
Venkatesu Jagadabi Physical Therapist - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 21916 Linden Blvd Ste A, Cambria Heights, NY 11411 Phone: 516-210-2077 |
News Archive
The Queensland Nurses Union has condemned health authorities for failing to act over concerns that their work places and residences in the Torres Straits are unsafe.
The disconnect between what Americans think of most provisions of Obamacare (love them!) and what they think of "Obamacare" (hate it!) has been the most perplexing aspect of rollout of the Affordable Care Act.
A device designed to improve adherence to outpatient parenteral antimicrobial therapy took top prize at the second IDEA Incubator, a competition showcasing inventions, products and devices to improve patient care for infectious diseases, which takes place during IDWeek.
Wayne State University School of Medicine researchers, working with colleagues in Canada, have found that one or more substances produced by a type of immune cell in people with multiple sclerosis (MS) may play a role in the disease's progression. The finding could lead to new targeted therapies for MS treatment.
Sanofi-aventis and its wholly-owned subsidiary, BiPar Sciences, today announced that The New England Journal of Medicine published the final phase II data for the investigational drug iniparib demonstrating significant clinical benefit in women with metastatic triple negative breast cancer when iniparib was administered in combination with chemotherapy agents gemcitabine/carboplatin.
› Verified 2 days ago